Administration of fertility treatments remains complex
Results of a new survey sponsored by Ferring Pharmaceuticals showthat only 30% of women undergoing fertility treatments are able toadminister the medications once a day, a frequency that is thoughtto reduce patient anxiety and administration errors. The survey wasconducted on-line by the National Infertility Association among 238respondents between the ages of 27 and 40.
Administration of fertility treatments remains complex
Results of a new survey sponsored by Ferring Pharmaceuticals show that only 30% of women undergoing fertility treatments are able to administer the medications once a day, a frequency that is thought to reduce patient anxiety and administration errors. The survey was conducted on-line by the National Infertility Association among 238 respondents between the ages of 27 and 40. More than half of the participants used both a needle/syringe and a pen for their daily injections, while one-third used just a needle and syringe, and 10% used only a pen. More patients reported that they were more anxious using a needle and syringe than a pen. Seventeen percent of patients reported very severe anxiety when they were required to inject their medications more than once a day. The National Infertility Association, also known as Resolve, was founded in 1974 to provide education, advocacy, and support on behalf of patients dealing with infertility.
To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
